534 related articles for article (PubMed ID: 22921742)
1. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.
Miyamae Y; Kurisu M; Murakami K; Han J; Isoda H; Irie K; Shigemori H
Bioorg Med Chem; 2012 Oct; 20(19):5844-9. PubMed ID: 22921742
[TBL] [Abstract][Full Text] [Related]
2. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of 3,5-di-O-caffeoylquinic acid on SH-SY5Y cells and senescence-accelerated-prone mice 8 through the up-regulation of phosphoglycerate kinase-1.
Han J; Miyamae Y; Shigemori H; Isoda H
Neuroscience; 2010 Sep; 169(3):1039-45. PubMed ID: 20570715
[TBL] [Abstract][Full Text] [Related]
4. Diverse ecdysterones show different effects on amyloid-β42 aggregation but all uniformly inhibit amyloid-β42-induced cytotoxicity.
Yang SG; Zhang X; Sun XS; Ling TJ; Feng Y; Du XY; Zhao M; Yang Y; Xue D; Wang L; Liu RT
J Alzheimers Dis; 2010; 22(1):107-17. PubMed ID: 20847437
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of caffeoylquinic acids on the accelerating activity on ATP production.
Miyamae Y; Kurisu M; Han J; Isoda H; Shigemori H
Chem Pharm Bull (Tokyo); 2011; 59(4):502-7. PubMed ID: 21467684
[TBL] [Abstract][Full Text] [Related]
6. Ellagic acid promotes Abeta42 fibrillization and inhibits Abeta42-induced neurotoxicity.
Feng Y; Yang SG; Du XT; Zhang X; Sun XX; Zhao M; Sun GY; Liu RT
Biochem Biophys Res Commun; 2009 Dec; 390(4):1250-4. PubMed ID: 19878655
[TBL] [Abstract][Full Text] [Related]
7. Copper inducing Aβ42 rather than Aβ40 nanoscale oligomer formation is the key process for Aβ neurotoxicity.
Jin L; Wu WH; Li QY; Zhao YF; Li YM
Nanoscale; 2011 Nov; 3(11):4746-51. PubMed ID: 21952557
[TBL] [Abstract][Full Text] [Related]
8. Dicyanovinyl-substituted J147 analogue inhibits oligomerization and fibrillation of β-amyloid peptides and protects neuronal cells from β-amyloid-induced cytotoxicity.
Kim K; Park KS; Kim MK; Choo H; Chong Y
Org Biomol Chem; 2015 Oct; 13(37):9564-9. PubMed ID: 26303522
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
[TBL] [Abstract][Full Text] [Related]
10. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
[TBL] [Abstract][Full Text] [Related]
11. Is the viscoelasticity of Alzheimer's Abeta42 peptide oligomers a general property of protein oligomers related to their toxicity?
Saraiva AM; Pereira MC; Brezesinski G
Langmuir; 2010 Jul; 26(14):12060-7. PubMed ID: 20515050
[TBL] [Abstract][Full Text] [Related]
12. Investigation on the influence of (Z)-3-(2-(3-chlorophenyl)hydrazono)-5,6-dihydroxyindolin-2-one (PT2) on β-amyloid(1-40) aggregation and toxicity.
Catto M; Arnesano F; Palazzo G; De Stradis A; Calò V; Losacco M; Purgatorio R; Campagna F
Arch Biochem Biophys; 2014 Oct; 560():73-82. PubMed ID: 25051344
[TBL] [Abstract][Full Text] [Related]
13. Identification of physiological and toxic conformations in Abeta42 aggregates.
Masuda Y; Uemura S; Ohashi R; Nakanishi A; Takegoshi K; Shimizu T; Shirasawa T; Irie K
Chembiochem; 2009 Jan; 10(2):287-95. PubMed ID: 19115328
[TBL] [Abstract][Full Text] [Related]
14. Characterizing amyloid-beta protein misfolding from molecular dynamics simulations with explicit water.
Lee C; Ham S
J Comput Chem; 2011 Jan; 32(2):349-55. PubMed ID: 20734314
[TBL] [Abstract][Full Text] [Related]
15. Internalisation and toxicity of amyloid-β 1-42 are influenced by its conformation and assembly state rather than size.
Vadukul DM; Maina M; Franklin H; Nardecchia A; Serpell LC; Marshall KE
FEBS Lett; 2020 Nov; 594(21):3490-3503. PubMed ID: 32871611
[TBL] [Abstract][Full Text] [Related]
16. Toxicity in rat primary neurons through the cellular oxidative stress induced by the turn formation at positions 22 and 23 of Aβ42.
Izuo N; Kume T; Sato M; Murakami K; Irie K; Izumi Y; Akaike A
ACS Chem Neurosci; 2012 Sep; 3(9):674-81. PubMed ID: 23019494
[TBL] [Abstract][Full Text] [Related]
17. Design of LVFFARK and LVFFARK-functionalized nanoparticles for inhibiting amyloid β-protein fibrillation and cytotoxicity.
Xiong N; Dong XY; Zheng J; Liu FF; Sun Y
ACS Appl Mater Interfaces; 2015 Mar; 7(10):5650-62. PubMed ID: 25700145
[TBL] [Abstract][Full Text] [Related]
18. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
Matharu B; El-Agnaf O; Razvi A; Austen BM
Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
[TBL] [Abstract][Full Text] [Related]
19. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
20. Multifunctionality of Acidulated Serum Albumin on Inhibiting Zn²⁺-Mediated Amyloid β-Protein Fibrillogenesis and Cytotoxicity.
Xie B; Dong X; Wang Y; Sun Y
Langmuir; 2015 Jul; 31(26):7374-80. PubMed ID: 26070334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
